Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Omani court sentences 2 foreigners to one month in prison for disturbing turtles
US Coast Guard suspends search for people on crashed medical aircraft
Brazil's Flavio Bolsonaro beats polls in presidential vote, faces Lula in runoff
Merz unveils fresh military aid in Kyiv, says Germany won't be intimidated
Protests demanding Indian election chief resigns escalate
